Rare Genomics Institute
Arvin Gouw is currently the Chief Executive Officer at Bacchus Therapeutics and Vice President of Research & Development at Rare Genomics Institute. With a background in cancer research, nanotechnology, and neurogenesis, Arvin has extensive experience in the field. Arvin has also pursued various degrees in oncology, business, law, philosophy, and theology, showcasing their diverse academic interests. Through their participation in programs like SPARK and their work at institutions like Stanford University School of Medicine, Arvin has demonstrated a commitment to advancing research discoveries in rare diseases and cancer.
This person is not in any offices
Rare Genomics Institute
Rare Genomics Institute (RG) was founded in 2011 to fill the health care gap for undiagnosed rare disease patients and support research in rare diseases.